CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current assets    
Cash $ 305 $ 1,341
Other current assets 398 97
Total current assets 703 1,438
Patent license rights, net 0 39
Total assets 703 1,477
Current liabilities    
Accounts payable 797 245
Other accrued liabilities 22 1
Total current liabilities 819 246
Secured debt and accrued interest, net of unamortized issuance costs 2,644 2,475
Capstone Therapeutics Corp. Stockholders' Equity    
Common Stock $.0005 par value; 150,000,000 shares authorized; 54,385,411 shares outstanding in 2019 and 2018 27 27
Additional paid-in capital 190,490 190,483
Accumulated deficit (193,277) (191,754)
Total Capstone Therapeutics Corp. stockholders' equity (deficit) (2,760) (1,244)
Noncontrolling interest 0 0
Total equity (2,760) (1,244)
Total liabilities and equity $ 703 $ 1,477